"Blood Viscosity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The internal resistance of the BLOOD to shear forces. The in vitro measure of whole blood viscosity is of limited clinical utility because it bears little relationship to the actual viscosity within the circulation, but an increase in the viscosity of circulating blood can contribute to morbidity in patients suffering from disorders such as SICKLE CELL ANEMIA and POLYCYTHEMIA.
| Descriptor ID |
D001809
|
| MeSH Number(s) |
G09.188.370.124 G09.330.380.630.110
|
| Concept/Terms |
Blood Viscosity- Blood Viscosity
- Blood Viscosities
- Viscosities, Blood
- Viscosity, Blood
|
Below are MeSH descriptors whose meaning is more general than "Blood Viscosity".
Below are MeSH descriptors whose meaning is more specific than "Blood Viscosity".
This graph shows the total number of publications written about "Blood Viscosity" by people in this website by year, and whether "Blood Viscosity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Blood Viscosity" by people in Profiles.
-
Rosenson RS, Lee ML, Chen Q. Association of total VLDL particle concentrations with elevated blood viscosity in patients with type 2 diabetes. Diabetes Res Clin Pract. 2022 Jan; 183:109180.
-
Rosenson RS, Chen Q, Najera SD, Krishnan P, Lee ML, Cho DJ. Ticagrelor improves blood viscosity-dependent microcirculatory flow in patients with lower extremity arterial disease: the Hema-kinesis clinical trial. Cardiovasc Diabetol. 2019 06 07; 18(1):77.
-
Rosenson RS, Chen Q, Najera SD, Lee ML, Cho DJ. Ticagrelor and the Prevention of Microvascular Complications in Diabetes Patients with Lower Extremity Arterial Disease; Rationale and Design of the Hema-Kinesis Trial. Cardiovasc Drugs Ther. 2018 10; 32(5):443-451.
-
Calhoun DA, Kirk JF, Christensen RD. Incidence, significance, and kinetic mechanism responsible for leukemoid reactions in patients in the neonatal intensive care unit: a prospective evaluation. J Pediatr. 1996 Sep; 129(3):403-9.